Effect of different interferonα2 preparations on IP10 and ET-1 release from human lung cells.
about
Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.Evidence for the involvement of type I interferon in pulmonary arterial hypertension.Pharmacological treatment of HIV-associated pulmonary hypertension.Evidence that pulmonary vascular pathology explains the decline in lung function associated with interferon α based therapies for chronic hepatitis C virus.
P2860
Effect of different interferonα2 preparations on IP10 and ET-1 release from human lung cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effect of different interferon ...... release from human lung cells.
@ast
Effect of different interferon ...... release from human lung cells.
@en
type
label
Effect of different interferon ...... release from human lung cells.
@ast
Effect of different interferon ...... release from human lung cells.
@en
prefLabel
Effect of different interferon ...... release from human lung cells.
@ast
Effect of different interferon ...... release from human lung cells.
@en
P2093
P2860
P1433
P1476
Effect of different interferon ...... release from human lung cells.
@en
P2093
Fernando Tatsch
Hime Gashaw
Jane A Mitchell
Neil A Galloway-Phillipps
Rekha Badiger
Stefan Foser
Thomas Singer
Tobias Manigold
Trevor T Hansel
P2860
P304
P356
10.1371/JOURNAL.PONE.0046779
P407
P577
2012-10-08T00:00:00Z